Modulation of Transcription Initiation Factor TFIID Subunit 1 (TAF1) for Treating Leukemia

摘要

The disclosure provides a method of treating leukemia, the method comprising administering to mammalian subject in need thereof an inhibitor of Transcription initiation factor TFIID subunit 1 (TAF1). The disclosure further provides a method of reducing the risk of leukemia, the method comprising administering to mammalian subject in need thereof an inhibitor of Transcription initiation factor TFIID subunit 1 (TAF1).